{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:25:34Z","timestamp":1767983134702,"version":"3.49.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamadermatol.2018.2516","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T16:36:36Z","timestamp":1535042196000},"page":"1184","source":"Crossref","is-referenced-by-count":22,"title":["Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa"],"prefix":"10.1001","volume":"154","author":[{"given":"Anna","family":"Campanati","sequence":"first","affiliation":[{"name":"Dermatological Clinic, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Orciani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Sorgentoni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Consales","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[{"name":"Dermatological Clinic, Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Di Primio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Sciences, Universit\u00e0 Politecnica delle Marche, Ancona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"10","key":"doi180040r1","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/ijd.2014.53.issue-10","article-title":"Hidradenitis suppurativa: the role of immune dysregulation.","volume":"53","author":"Kelly","year":"2014","journal-title":"Int J Dermatol"},{"issue":"4","key":"doi180040r2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.2015.29.issue-4","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa.","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi180040r3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa).","volume":"2","author":"Fimmel","year":"2010","journal-title":"Dermatoendocrinol"},{"issue":"1","key":"doi180040r4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/bjd.2016.174.issue-1","article-title":"Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa\u2013acne inversa: evidence from the National Italian Registry [published correction appears in Br J Dermatol. 2017;176(6):1678].","volume":"174","author":"Bettoli","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi180040r5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory mechanisms in hidradenitis suppurativa.","volume":"34","author":"Kelly","year":"2016","journal-title":"Dermatol Clin"},{"issue":"6","key":"doi180040r6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5114\/reum.2016.64910","article-title":"Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab.","volume":"54","author":"Bosnic","year":"2016","journal-title":"Reumatologia"},{"issue":"5","key":"doi180040r7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2133.2011.10224.x","article-title":"Hidradenitis suppurativa: a disease of the absent sebaceous gland? sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa.","volume":"164","author":"Kamp","year":"2011","journal-title":"Br J Dermatol"},{"issue":"7","key":"doi180040r8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/archderm.1988.01670070031014","article-title":"Hidradenitis suppurativa: glucose tolerance, clinical, microbiologic, and immunologic features and HLA frequencies in 27 patients.","volume":"124","author":"O\u2019Loughlin","year":"1988","journal-title":"Arch Dermatol"},{"key":"doi180040r9","doi-asserted-by":"publisher","first-page":"2450401","DOI":"10.1155\/2017\/2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa.","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"11","key":"doi180040r10","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis suppurativa is characterized by dysregulation of the Th17:Treg cell axis, which is corrected by anti-TNF therapy.","volume":"137","author":"Moran","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi180040r11","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/bjd.14247","article-title":"Cytokine analysis in hidradenitis suppurativa supports therapeutic approaches.","volume":"173","author":"Prens","year":"2015","journal-title":"Br J Dermatol"},{"issue":"10","key":"doi180040r12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments.","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"issue":"1","key":"doi180040r13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/bjd.2007.156.issue-1","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa.","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi180040r14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","article-title":"Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.","volume":"148","author":"Dr\u00e9no","year":"2012","journal-title":"Arch Dermatol"},{"issue":"6","key":"doi180040r15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/exd.2004.13.issue-6","article-title":"Lipid raft\u2013enriched stem cell\u2013like keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa.","volume":"13","author":"Gniadecki","year":"2004","journal-title":"Exp Dermatol"},{"issue":"10","key":"doi180040r16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00403-014-1493-3","article-title":"Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17\/Th2 imbalance of psoriasis.","volume":"306","author":"Campanati","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"doi180040r17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/bjd.15078","article-title":"T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.","volume":"176","author":"Orciani","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi180040r18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjd.2011.165.issue-3","article-title":"The mesenchymal stem cell profile in psoriasis.","volume":"165","author":"Orciani","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"doi180040r19","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/bjd.2013.168.issue-5","article-title":"Oxidative stress and psoriasis: the effect of antitumour necrosis factor-a inhibitor treatment.","volume":"168","author":"Bacchetti","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi180040r20","doi-asserted-by":"publisher","first-page":"e00191","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells - current trends and future prospective.","volume":"35","author":"Ullah","year":"2015","journal-title":"Biosci Rep"},{"issue":"11","key":"doi180040r21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"doi180040r22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"doi180040r24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement.","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"1","key":"doi180040r25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.7861\/clinmedicine.16-1-70","article-title":"Hidradenitis suppurativa: an update.","volume":"16","author":"Ingram","year":"2016","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"doi180040r26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jdermsci.2016.11.006","article-title":"Stem cells in psoriasis.","volume":"86","author":"Hou","year":"2017","journal-title":"J Dermatol Sci"},{"issue":"1","key":"doi180040r27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0300060515593229","article-title":"The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis.","volume":"44","author":"Campanati","year":"2016","journal-title":"J Int Med Res"},{"issue":"1","key":"doi180040r28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.2012.167.issue-1","article-title":"Effect of biologic therapies targeting tumour necrosis factor-a on cutaneous mesenchymal stem cells in psoriasis.","volume":"167","author":"Campanati","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi180040r29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2340\/00015555-1492","article-title":"Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.","volume":"93","author":"Mozeika","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"doi180040r30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/1744666X.2016.1221762","article-title":"Adalimumab for the treatment of hidradenitis suppurativa\/acne inversa.","volume":"12","author":"Zouboulis","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"doi180040r31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa.","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi180040r32","first-page":"1534","article-title":"Interleukin-12 and interferon-gamma. Do they always go together?","volume":"147","author":"Trinchieri","year":"1995","journal-title":"Am J Pathol"},{"issue":"6","key":"doi180040r33","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-a, interleukin (IL)-1\u00df and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-a and IL-1\u00df.","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi180040r34","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4049\/jimmunol.0903907","article-title":"Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa.","volume":"186","author":"Wolk","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"doi180040r35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"issue":"6","key":"doi180040r36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"key":"doi180040r37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mad.2017.11.004","article-title":"The role of TGF\u00df in wound healing pathologies.","volume":"172","author":"Kiritsi","year":"2018","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"doi180040r38","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.3892\/mmr.2017.6437","article-title":"Expression of TGF-\u00df1\/mTOR signaling pathway in pathological scar fibroblasts.","volume":"15","author":"Zhai","year":"2017","journal-title":"Mol Med Rep"},{"key":"doi180040r23","unstructured":"RothV. Doubling Time Computing [computer program]. Version 3.1.0. http:\/\/www.doubling-time.com. Published 2006. Accessed January 10, 2018."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jamadermatology\/fullarticle\/2697218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T20:09:53Z","timestamp":1539202193000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.2516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.2516","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}